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Article 5

Drs. Kendra Bence (left) and Erika Krick
VMKLX VIZMI[VIGIRXWXYH]½RHMRKW[LMPI
Penn Vet student Nadia Azam observes.

BY DENISE FOLEY

Advancing the Field {TOGETHER}
A hallmark of Penn Vet, collaboration is a daily exercise
for researchers, students, clinicians and colleagues

You can’t whistle a symphony, a wise man
once said. It takes an entire orchestra to play
it. At Penn Vet, the ability to collaborate
with others has allowed researchers to create
some beautiful music, not to mention elegant
science, together with colleagues, researchers
from around the world, industry and even
students from other academic institutions.
Collaboration can yield valuable results, as
these examples illustrate.
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Combating Cachexia in Cats
Kendra K. Bence, PhD and Erika L. Krick, VMD joke that
they met “speed dating.” That’s what organizers called the
ice-breaking exercise at an annual faculty retreat that threw
together staffers with similar interests who otherwise might
never talk to one another. That day, Drs. Bence and Krick
found themselves at the same table; today, they’re at the
same bench. The two are collaborating on a translational
study looking at the similarities in cats and humans of
cachexia, a metabolic wasting syndrome that occurs in cancer
— often GI cancers — and other diseases.
It’s the perfect melding of professional interests. Dr. Bence
is an assistant professor in the animal biology department
where she studies the cellular mechanism of feeding and
obesity in mice that serve as stand-ins for the humans caught
in the double epidemic of obesity and diabetes. Dr. Krick
is a clinical veterinary oncologist with a special interest

in studying and treating cats with lymphoma and cachexia.
They’ve been joined by second-year Penn Vet student
Nadia Azam (V’14) who was awarded a Merial scholarship
to participate in the research. The Veterinary Clinical
Investigation Center (VCIC) is also involved.

“Surprisingly we found no change in NPY and AGRP with
fasting, but we did see the expected suppression of POMC
and CART,” said Dr. Bence. “As we go on, we may need
to expand the number of neuropeptides we examine. It may
have been that the fast we did [overnight] with the cats wasn’t
long enough to see changes in orexigenic peptides. Or it may
be that cats utilize alternate neuropeptides in their response to
feeding and hunger compared to other species.”
Ultimately, the researchers would like to discover a marker
that would alert a clinician — like Dr. Krick — that an animal
is more likely to develop cachexia.
“Then,” said Dr. Bence, “it’s not out of the question
that we could design new treatment strategies for our feline
patients that can be translated to humans.”

Sharing a Living Laboratory

Dr. Krick examines a patient with cachexia.

Patients with cachexia — both feline and human —
experience a loss of appetite, weight and muscle mass that isn’t
remedied by supplements or extra calories. They also respond
poorly to cancer treatment.
“Cats who are skinny and not feeling well from their cancer
may not tolerate standard chemotherapy doses. Sometimes
they are given lower doses of chemotherapy, which could
decrease the chance that they will respond,” said Dr. Krick,
who is also collaborating with researchers at Texas A&M
University on a study of feline lymphoma. “Also, we have
found that cats that lose weight during treatment have a
significantly shorter survival time than cats that don’t lose
weight.”
In fact, she says, as many as 30 percent of people with
cancer cachexia die from the condition.
The villain? Likely pro-inflammatory cytokines, elevated
in cancer cachexia patients, that speed muscle loss, decrease
intestinal motility and gastric emptying leading to early satiety,
and alter production of hypothalamic neuropeptides that
govern appetite.
The first aim of the study is to discover if cachectic cats
with cancer have different inflammatory markers than healthy
cats and those with cancer but who aren’t cachectic. The
researchers are also looking at the gene expression of appetite
controlling peptides in the brain, specifically the orexigenic
neuropeptides NPY and AGRP that stimulate eating, and
the anorexic neuropeptides POMC and CART that suppress
the desire to feed. Preliminary results have been partially
unexpected, but intriguing.

Sue McDonnell, PhD, head of the Havemeyer Equine
Behavior Research Program at Penn Vet’s New Bolton
Center, has learned that when you build a better herd,
everyone will beat a path to your pasture.
The herd, in this case, is made up of 95 semi-feral ponies
that roam 35 acres of lush grassland at the New Bolton Center
in Kennett Square. Since the herd was started in 1994 (with
13 mares and 13 stallions from domestic stock), it has become
a living laboratory, drawing not only equine researchers and
clinicians from around the world, but high school students,
university undergrads and graduate students, and vet tech and
nursing students who might never have an opportunity to
observe horses in the wild.
Or, in this case, the semi-wild. Penn Vet’s ponies forage,
mate when they want to, get plenty of exercise because
they’re never indoors, but, unlike wild horses, are acclimated
to humans who provide some minimal veterinary care — and
come to watch. (With a housing development abutting one

Dr. McDonnell’s semi-feral pony herd serves as a living laboratory for
Penn Vet students and researchers as well as for area universities.
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Ensuring a Safer Egg
Penn Vet researcher leads charge in
developing safe-egg testing kit for FDA

I

n August 2010, an outbreak of Salmonella Enteritidis
(SE) was responsible for illness in almost 2,000 people
in at least 25 states. More than 550 million eggs were
recalled from the market. While methods have been in
place to test for the presence of SE in eggs, the traditional
methodology is time consuming, requiring up to 10 days to
determine the presence or absence of SE in egg samples.

Mare and foal behavior is just one of the many interactions Dr.
McDonnell and her team study in the semi-feral pony herd.

pasture, they likely also get supplemental treats from young
neighbors despite a large “don’t feed the ponies” warning on
the fence.)
“It’s not exactly like going to see wild horses. They are
contained, but that’s the beauty of it,” said Dr. McDonnell,
who has been at Penn Vet since 1981. “We’ve seen them
every day since 1994, and because their wandering is limited
to the pasture enclosure we can observe the whole herd so
we know a lot more about their natural social organization
than we would if they were out west where the terrain is so
tough and the forage is so sparse that the horses are spread out.
There, the best you can do is stay with one family at a time,
so you are unable to readily understand the social interactions
among families.”
But it’s more than just convenience that lures researchers
and students (from places like the University of Delaware,
Delaware Valley College of Science and Agriculture, Penn
State, Cazenovia College and Penn’s own psychology
department) to this classroom on the hoof. It’s also what’s
been — and can be — learned there.
“Once you get students attuned to natural horse behavior,
they see that most health problems in horses have resulted
from how we manage them,” said Dr. McDonnell.
The Penn Vet herd doesn’t experience the same health
problems as domestic equines. There’s no colic, no laminitis
and no sexual dysfunction, the bane of many breeders who
also come to consult with Dr. McDonnell.
Since the herd has become a lure for students, said Dr.
McDonnell, the center has created short courses specifically
for them that their own institutions have neither the resources
nor faculty to provide. As a bonus, she says, “these courses
generate funds that help to support the herd.”
There have been some other unanticipated benefits of what
could be called Penn Vet’s open pasture gate policy.
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Recognizing that this timeframe wasn’t acceptable, the
microbiology laboratory at Penn Vet’s New Bolton Center
LEWTPE]IHEWMKRM½GERXVSPIMRXLIHIZIPSTQIRXSJVETMH
7)WTIGM½GQSPIGYPEVHMEKRSWXMGQIXLSHW8LITSP]QIVEWI
chain reaction (PCR) test developed at Penn Vet allows
quick determination of the presence or absence of SE in
egg samples, and provides accurate results in approximately
27 hours – a tenfold reduction in waiting time for results.
This methodology came in handy for the Federal Egg
Safety Program, which requires all large-scale producers in
the US to test for SE before products reach consumers.
As a result, the Salmonella Enteritidis Detection Kit was
developed by Shelley Rankin, PhD, associate professor of
microbiology at Penn Vet and chief of NBC’s microbiology,
in collaboration with The Life Technologies Corporation,
which allows producers to quickly test their eggs for SE.
FDA-approved for use in the Federal Egg Safety Program
in early 2011, the kit was validated by Dr. Rankin’s lab.
“Penn Vet has been collaborating with the Commonwealth
of Pennsylvania to ensure food safety for decades,” said
Joan C. Hendricks, VMD, PhD, the Gilbert S. Kahn Dean
of Penn Vet. “The adoption of our egg-testing protocols
by the FDA illustrates our researchers’ success in their
½IPHERHXLIMQTSVXERGIXLEXZIXIVMREV]VIWIEVGLIVW
play in ensuring public health and food safety. I am
thrilled that Penn Vet is continuing to lead the way in
setting the standard in food safety and public health.”
“The FDA equivalence determination for this test marks
a milestone for the egg industry in this country,” said Dr.
6EROMR±8LI'SQQSR[IEPXL[EWXLI½VWXWXEXIMRXLI
nation to initiate a voluntary egg quality assurance program
and the Pennsylvania Animal Diagnostic Laboratory System
[MPPFIXLI½VWXXSMQTPIQIRXXLMWRI[PIZIPSJXIWXMRK
It’s very exciting that the FDA has adopted this test for
the Federal Egg Safety Program. This action demonstrates
their commitment to delivering the safest quality food to
the consumer and I’m proud to be a part of that trend.”
Penn Vet has been active in the development and
implementation of the state’s PEQAP (Pennsylvania Egg
Quality Assurance Program), and much of what has been
learned and shared by PEQAP forms the basis for the
national Egg Safety Program. Dr. Rankin has more than 20
years experience in the detection and characterization
of Salmonella from human and animal sources.

—Sally Silverman

“We get the opportunity to meet some real star students,
some of whom are inspired to study vet medicine and apply to
Penn,” said Dr. McDonnell.
And in one case, a student from the University of Delaware
launched an ongoing independent study based on a Penn Vet
project using recorded stallion vocalizations and stallion scent
for estrus detection in mares. It’s allowing Dr. McDonnell and
her colleagues to find a solution for a problem that faces small
farmers but which can’t be tested in the Penn Vet research and
teaching herd.
“Our mares are exposed to stallions on the property, but
what if you’re out in the middle of nowhere with no stallions
around,” she said. “At the University of Delaware, they had
only a few mares at the time and no stallion. This project by
one of our student visitors gives us the opportunity to do a
real-world test of the problem.”

Predicting Epileptic Seizures
for Novel Treatment Options
When it comes to epilepsy, dogs and humans have much in
common. Their rate of idiopathic epilepsy is about the
same. And their treatment options are similar — and equally
inadequate.
“The problem for people with epilepsy is they may have
a seizure once or twice a year, but they’re on medication all
year,” said Charles Vite, DVM, PhD, assistant professor of
neurology and neurosurgery in the Department of Clinical

Drs. Brian Litt and Charles Vite are working together to help humans and animals
with epilepsy.

Studies at Penn Vet. “These drugs are not benign. They can
have side effects, including cognitive dysfunction, depression
and liver failure.”
And for over 30 percent of people — and dogs — the
drugs don’t adequately control seizures.
But here’s where dogs and people differ. Epilepsy doesn’t
usually dramatically circumscribe a dog’s life. It does for
humans.
“People with epilepsy can’t drive, they have a hard time
holding down certain jobs and they take a lot of drugs,”
said Dr. Vite. “But what if they could predict when they
were going to have a seizure, or when a seizure was likely to
happen? If they had a box that would flash blue when they

were okay they could say, ‘Great, it’s blue today, I can drive,’
that would be a wonderful thing.”
Through a collaboration involving Penn Vet, NeuroVista,
a premier medical technology developer with Penn Vet
connections, and researchers at the Mayo Clinic, University
of Minnesota and the University of California at Davis, that
“wonderful thing” is one step closer to reality. The team is
expecting to receive a translational research grant this fall and
are awaiting a funding decision.
Dr. Vite, Penn neurologists Kathryn A. Davis, MD,
and Brian Litt, MD, along with the VCIC, joined Mayo,
University of Minnesota and UC-Davis researchers to test an
implantable device in dogs that may predict a “perfect storm”
in the brain’s electrical system that signals a seizure — before
it even happens. The device was developed by NeuroVista, a
Seattle firm specializing in implantable neurological products.
Dr. Litt is a scientific advisor to the company; its vice
president of clinical research is Penn Vet alum and Medical
Scientist Training Program graduate W. Douglas Sheffield,
VMD, PhD.
The device includes implantable (subdural) strip monitoring
electrodes and a sub-dermal telemetry unit which wirelessly
transmits EEG signals to an external personal advisory device
(PAD), much like a pager, with colored lights — including
the blue one Dr. Vite was talking about — as well as vibrating
and audible alarms. The data is collected on ordinary flash
memory cards and can be downloaded to a computer for
storage and analysis.
The results of the first test, in six dogs with naturally
occurring epilepsy, was published this year in the journal
Epilepsy Research. Analyzing more than 11,000 continuous
hours of iEEG data and clinical observation, the researchers
found that canine epilepsy is “a promising model” for human
epilepsy for testing implantable devices: When having seizures,
dogs and humans share similar patterns in brain activity and
observable symptoms.
Though far from market-ready, the device has the potential
to exert profound effects on epilepsy research and care.
“If we are able to give people with epilepsy or a dog owner
one-to-two hours notice before a seizure occurs, this will represent a massive change in how we treat epilepsy,” said Dr. Vite.
Instead of taking drugs every day, a person with epilepsy
may be able to take a fast-acting antiepileptic drug only on
days when a seizure warning is sounded.
While the long-range goal of the study is to find better
ways to treat human patients, Dr. Vite said, “As I remind
everyone, I’m a vet. I’m here to help dogs and cats.” In fact,
he says, he has about 600 active epilepsy cases and this month
[October] he launched a weekly clinic strictly for epileptic
animals.
Fortunately, whatever the research in dogs uncovers to help
humans will also help animals.
“It could give us more options to offer when we get calls
from owners and breeders asking if there’s anything new for
epilepsy,” said Dr. Vite.
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